Document Detail


Effect of chronic propranolol treatment on bone changes of secondary hyperparathyroidism in dialysis patients.
MedLine Citation:
PMID:  7177287     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To assess the effect of long-term propranolol therapy on uremic osteodystrophy, we evaluated retrospectively the biochemical, X-ray, and bone histological changes in 9 dialysed hypertensives who had been on propranolol treatment for periods ranging from 1 to 8 years. The control group included 9 well-matched dialysed uremics never treated with beta-blockers. The two groups did not differ in serum ionized calcium or iPTH levels. The incidence of bone resorption evaluated on X-ray findings and on bone biopsy specimens was of a comparable degree in the two groups. Our data show that propranolol even if started early in the course of renal failure, is of no benefit in preventing uremic bone disease.
Authors:
F Pizzarelli; C Zoccali; C Ciccarelli; Q Maggiore; E Bonucci; P Ballanti
Related Documents :
1361827 - Low turnover bone disease is the more common form of bone disease in capd patients.
22175657 - Retrospective evaluation of the clinical benefit of long-term continuous use of zoledro...
10930487 - Target-specific rib biopsy using the gamma probe.
9501957 - Ovariectomy-induced changes in aged beagles: histomorphometry of rib cortical bone.
3475287 - Deliberate, fixed extra-articular obstruction. treatment of choice for subluxation and ...
16166837 - Bone scintigraphy in common tumors with osteolytic components.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Nephron     Volume:  32     ISSN:  0028-2766     ISO Abbreviation:  Nephron     Publication Date:  1982  
Date Detail:
Created Date:  1983-02-14     Completed Date:  1983-02-14     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0331777     Medline TA:  Nephron     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  93-4     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bone Resorption / drug effects
Humans
Hyperparathyroidism, Secondary / drug therapy*
Kidney Failure, Chronic / complications*,  therapy
Propranolol / therapeutic use*
Renal Dialysis*
Renal Osteodystrophy / drug therapy*
Chemical
Reg. No./Substance:
525-66-6/Propranolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thioflavin T fluorescence in membranoproliferative glomerulonephritis.
Next Document:  Renal phosphate handling in nephrotic syndrome during water immersion.